Report ID : 10085609 |
Published Date : 21 Mar 2025 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
Global Carotid Artery Disease Market Highlights Over 2022 - 2031
The global carotid artery disease market is estimated to grow at a ~4% CAGR over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a notable revenue in 2021. The growth of the market can be attributed to the rise in the prevalence of diseases, such as diabetes, obesity, high blood pressure, and others. Moreover, there has been a rise in the bad living habits of the people that are contributing to the several diseases, which in turn, is projected to contribute to the growth of the market in the coming years. As per the World Health Organization, approximately 30 million children under the age of 5 were found to be obese in 2020. Moreover, the advancement in the treatment of stroke is expected to drive the growth of the global carotid artery disease market.
GET A SAMPLE COPY OF THIS REPORT
The global carotid artery disease market is segmented by end-users into research and academic institute, hospitals, clinics, ambulatory surgical centers, and others. Out of which, the hospitals segment is anticipated to hold the major share during the forecast period owing to the better facilities and advanced technologies present in hospitals for the treatment of patients.
Global Carotid Artery Disease Market Regional Synopsis
Regionally, the global carotid artery disease market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of the increase in the aged population and a rise in the cases of carotid artery disease amongst these populations. As per the World Bank, India’s percentage of the population aged 65 and above has increased from 3 percent in 1960 to 7 percent in 2020. Therefore, it is expected to surge the growth of the carotid artery disease market in the region.
Market Segmentation
Our in-depth analysis of the global carotid artery disease market includes the following segments:
By End-Users
-
Research and Academic Institute
-
Hospitals
-
Clinics
-
Ambulatory Surgical centers
-
Others
By Application
-
Treatment
-
Diagnosis
Growth Drivers and Challenges Impacting the Growth of the Global Carotid Artery Disease Market
Growth Drivers
-
Advancement in the treatment of the stroke
-
Rise in the bad living habits of the people
Challenges
-
Strictness by the regulatory bodies related to the treatment of carotid artery disease
-
High cost for the treatment of carotid artery disease
Key Companies Dominating the Global Carotid Artery Disease Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global carotid artery disease market that are included in our report are Boston Scientific Corporation, Hitachi, Ltd., Abbott, Becton, Dickinson and Company, Stryker, Medtronic, W.L. Gore & Associates, Inc., Terumo Corporation, Silk Road Medical, Inc., Pfizer Inc., and others.
Latest Developments in the Global Carotid Artery Disease Market:
-
28 April 2022: Medtronic announced the collaboration with GE Healthcare to address the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Laboratories (OBLs). Customers will be able to access extensive product portfolios, financial solutions, and exceptional service as a result of this new collaboration.
-
3 February 2022: Abbott, announced that UnitedHealthcare (UHC), the largest private health insurance company in the United States, has updated its 'Implanted Electrical Stimulator for Spinal Cord' medical policy to allow patients with chronic pain access to Abbott's dorsal root ganglion (DRG) neurostimulation devices when medical policy criteria are met.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
